.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

McKesson
Medtronic
Novartis
Julphar
Argus Health
Chinese Patent Office
Express Scripts
Fish and Richardson
Cipla
Cantor Fitzgerald

Generated: November 22, 2017

DrugPatentWatch Database Preview

E-MYCIN Drug Profile

« Back to Dashboard

What is the patent landscape for E-mycin, and when can generic versions of E-mycin launch?

E-mycin is a drug marketed by Arbor Pharms Inc and Pharmacia And Upjohn and is included in two NDAs.

The generic ingredient in E-MYCIN is erythromycin ethylsuccinate. There are ninety-nine drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the erythromycin ethylsuccinate profile page.
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Arbor Pharms Inc
E-MYCIN
erythromycin
TABLET, DELAYED RELEASE;ORAL060272-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Pharmacia And Upjohn
E-MYCIN E
erythromycin ethylsuccinate
SUSPENSION;ORAL062198-002Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Arbor Pharms Inc
E-MYCIN
erythromycin
TABLET, DELAYED RELEASE;ORAL060272-002Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Pharmacia And Upjohn
E-MYCIN E
erythromycin ethylsuccinate
SUSPENSION;ORAL062198-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Cipla
Cantor Fitzgerald
Cerilliant
Chubb
Chinese Patent Office
Accenture
Novartis
Queensland Health
Fish and Richardson
Julphar

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot